Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-25EMA Authorised: Nintedanib Accord (nintedanib) — Accord Healthcare S.L.U.
EU authorization of Nintedanib Accord for idiopathic pulmonary fibrosis and related interstitial lung diseases, expanding treatment options …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Role of Genetic Factors in the Development of Lung Disease
NHLBI-backed clinical trial is recruiting to study the role of genetic factors in the development of lung disease, including cystic fibrosis…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Analysis of Specimens From Individuals With Pulmonary Fibrosis
NHGRI-sponsored trial update describing analysis of specimens from individuals with pulmonary fibrosis (including Hermansky-Pudlak syndrome)…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Efficacy of Osteopathic Manipulative Techniques With Progressive Pulmonary Fibrosis Patients [NA]
This clinical trial update reviews the efficacy of osteopathic manipulative techniques in patients with progressive pulmonary fibrosis, and …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Advanced Imaging for Pulmonary Fibrosis [Phase 2]
A Phase 2 clinical trial exploring advanced imaging for pulmonary fibrosis is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to Treatment [Phase 1, Phase 2]
The document reports the completion of a Phase 1/2 clinical trial evaluating intravenous infusion of allogeneic mesenchymal stem cells deriv…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Dyspnea and Idiopathic Pulmonary Fibrosis
A clinical trial investigating dyspnea in idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis [Phase 3]
This is a Phase 3 long-term extension trial to evaluate the safety and tolerability of Admilparant in participants with pulmonary fibrosis; …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis [Phase 2]
Phase 2 clinical trial evaluating inhaled AP01 for progressive pulmonary fibrosis is currently recruiting, with no results yet reported.
-
CLINICAL_TRIALS other · 2026-03-31Clinical Trial Update: Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary Fibrosis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of HSK44459 for progressive pulmonary fibrosis; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: MRI Quantification of Pulmonary Fibrosis in Scleroderma Patients [NA]
A completed clinical trial evaluating MRI-based quantification of pulmonary fibrosis in patients with systemic sclerosis (scleroderma) to as…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis
ClinicalTrials.gov update on a trial examining outcomes and immunotherapy for patients with lung cancer and pulmonary fibrosis; the study is…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis [Phase 2]
A Phase 2 clinical trial update on developing FAPI PET imaging as a non-invasive biomarker for pulmonary fibrogenesis, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases [Phase 1, Phase 2]
This clinical trial update reports ongoing Phase 1/2 studies evaluating the Ga-68-labeled NI-FAPI-04 PET/CT imaging agent for fibroblast act…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Clinical Application of 68Ga-1A12 PET in Fibrosis-related Diseases
An ongoing clinical trial is evaluating the 68Ga-1A12 PET tracer for fibrosis-related diseases, including pulmonary fibrosis. The study is n…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Telomeres Length in Israeli Fibrotic ILD Patients
The entry notes an ongoing clinical trial enrolling by invitation to study telomere length in Israeli patients with fibrotic interstitial lu…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF10073 After Single and Multiple Doses in Healthy Volunteers and the Effect of Itraconazole on CHF10073 Exposure [Phase 1]
This Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of inhaled CHF10073 in healthy volunteers, including the effect …
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis
A clinical trial evaluating inspiratory effort via nasal pressure measurement in patients with idiopathic pulmonary fibrosis is currently re…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: HOXB7 and Linked Tissue and Blood Biomarkers in the Lungs of Patients With Pulmonary Fibrosis
This registry entry outlines a study assessing HOXB7 and related tissue and blood biomarkers in the lungs of patients with pulmonary fibrosi…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers [NA]
The update notes the SUPPORT-T trial is recruiting patients with progressive pulmonary fibrosis and their caregivers, sponsored by the Medic…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Diaphragmatic Function as a Biomarker
This RWTH Aachen University trial evaluates diaphragmatic function as a biomarker in patients with asthma, COPD, pulmonary fibrosis, and pul…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Pulmonary Fibrosis During Severe COVID-19 Pneumonia
This clinical trial update reports research on pulmonary fibrosis in patients with severe COVID-19 pneumonia (SARS-CoV-2–related ARDS), with…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Western Sweden Systemic Sclerosis Project
A systemic sclerosis (scleroderma) trial in Western Sweden, sponsored by Sahlgrenska University Hospital, is currently recruiting and evalua…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Post Acute Sequelae of COVID-19
An active-but-not-recruiting clinical trial at Vanderbilt University Medical Center studying post-acute sequelae of COVID-19, including mani…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Explanted Lung Tissues With Pulmonary Fibrosis
Clinical trial update describing a study evaluating explanted lung tissues from patients with pulmonary fibrosis, currently recruiting.